De Simone Francesco, Cassarà Luigi, Sardo Salvatore, Scarparo Elena, Saleh Omar, Nigro Neto Caetano, Zangrillo Alberto, Landoni Giovanni
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Ann Card Anaesth. 2017 Oct-Dec;20(4):399-402. doi: 10.4103/aca.ACA_50_17.
Myocardial injury during cardiac surgery on cardiopulmonary bypass (CPB) is a major determinant of morbidity and mortality. Preclinical and clinical evidence of dose- and time-related cardioprotective effects of volatile anesthetic drugs exist and their use during the whole surgery duration could improve perioperative cardiac protection. Even if administering volatile agents during CPB are relatively easy, technical problems, such as waste gas scavenging, may prevent safe and manageable administration of halogenated vapors during CPB.
The aim of this study is to improve the safe administration of volatile anesthesia during CPB.
Tertiary teaching hospital.
We describe an original device that collects and disposes of any volatile anesthetic vapors present in the exit stream of the oxygenator, hence preventing its dispersal into the operating theatre environment and adaptively regulates pressure of oxygenator chamber in the CPB circuit.
We have so far applied a prototype of this device in more than 1300 adult cardiac surgery patients who received volatile anesthetics during the CPB phase.
Widespread implementation of scavenging system like the one we designed may facilitate the perfusionist and the anesthesiologist in delivering these cardioprotective drugs with beneficial impact on patients' outcome without compromising on safety.
体外循环(CPB)心脏手术期间的心肌损伤是发病率和死亡率的主要决定因素。挥发性麻醉药物存在剂量和时间相关的心脏保护作用的临床前和临床证据,在整个手术过程中使用这些药物可能会改善围手术期的心脏保护。即使在CPB期间给予挥发性药物相对容易,但诸如废气清除等技术问题可能会妨碍在CPB期间安全且可管理地给予卤化蒸汽。
本研究的目的是改善CPB期间挥发性麻醉的安全给药。
三级教学医院。
我们描述了一种原始装置,该装置收集并处理氧合器出口气流中存在的任何挥发性麻醉蒸汽,从而防止其扩散到手术室环境中,并能自适应调节CPB回路中氧合器腔室的压力。
到目前为止,我们已将该装置的原型应用于1300多名在CPB阶段接受挥发性麻醉的成年心脏手术患者。
像我们设计的这种清除系统的广泛实施可能会帮助灌注师和麻醉师在不影响安全性的情况下给予这些具有心脏保护作用的药物,对患者的预后产生有益影响。